Robert Brenner - 03 Jan 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Reporting relationship: Chief Medical Officer
Issuer ticker: VERA
Reported as of: 03 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jan 2024, 08:17:02 UTC
Next SEC filing: 20 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Joseph R. Young, Attorney-in-Fact

Filing notes and source

Key filing fact

Robert Brenner filed Form 4 for Vera Therapeutics, Inc. (VERA) on 08 Jan 2024.

Key facts

This page summarizes Robert Brenner's Form 4 filing for Vera Therapeutics, Inc. (VERA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jan 2024, 08:17.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VERA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +350,000
Change %
Price: $0.000000
Shares after: 350,000
Date: 03 Jan 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 350,000
Exercise price: $15.36
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/4 of the shares subject to the option vest on January 3, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.